Description 
The 2026 CKM guideline formalizes interdisciplinary, team-based care for patients with overlapping cardiovascular, kidney, and metabolic disease, centering a named CKM coordinator to dismantle clinical silos and drive guideline-directed medical therapy (GDMT). The coordinator—often a nurse navigator, pharmacist, or care manager—serves as the single point of contact who schedules follow-up, reconciles medications, facilitates communication among cardiology, nephrology, endocrinology, primary care and community services, and supports patients with behavioral and social barriers. By assigning ownership for titration and monitoring, the model targets therapeutic inertia and reduces fragmentation that causes missed opportunities for organ-protective therapy. The guideline pairs this structural role with standardized care pathways addressing physical activity, nutrition, weight, blood pressure, glycemic control, and lipids, and recommends performance tracking for therapy receipt. For administrators, the model translates into defined staffing, shared workflows, and metrics; for clinicians, it creates a practical mechanism to deliver integrated, patient-centered CKM care.